Correlation Between Foghorn Therapeutics and Nurix Therapeutics
Can any of the company-specific risk be diversified away by investing in both Foghorn Therapeutics and Nurix Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Foghorn Therapeutics and Nurix Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Foghorn Therapeutics and Nurix Therapeutics, you can compare the effects of market volatilities on Foghorn Therapeutics and Nurix Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Foghorn Therapeutics with a short position of Nurix Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Foghorn Therapeutics and Nurix Therapeutics.
Diversification Opportunities for Foghorn Therapeutics and Nurix Therapeutics
0.31 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Foghorn and Nurix is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Foghorn Therapeutics and Nurix Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nurix Therapeutics and Foghorn Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Foghorn Therapeutics are associated (or correlated) with Nurix Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nurix Therapeutics has no effect on the direction of Foghorn Therapeutics i.e., Foghorn Therapeutics and Nurix Therapeutics go up and down completely randomly.
Pair Corralation between Foghorn Therapeutics and Nurix Therapeutics
Given the investment horizon of 90 days Foghorn Therapeutics is expected to generate 1.13 times less return on investment than Nurix Therapeutics. In addition to that, Foghorn Therapeutics is 1.4 times more volatile than Nurix Therapeutics. It trades about 0.04 of its total potential returns per unit of risk. Nurix Therapeutics is currently generating about 0.07 per unit of volatility. If you would invest 922.00 in Nurix Therapeutics on August 29, 2024 and sell it today you would earn a total of 1,257 from holding Nurix Therapeutics or generate 136.33% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Foghorn Therapeutics vs. Nurix Therapeutics
Performance |
| Timeline |
| Foghorn Therapeutics |
| Nurix Therapeutics |
Foghorn Therapeutics and Nurix Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Foghorn Therapeutics and Nurix Therapeutics
The main advantage of trading using opposite Foghorn Therapeutics and Nurix Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Foghorn Therapeutics position performs unexpectedly, Nurix Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nurix Therapeutics will offset losses from the drop in Nurix Therapeutics' long position.| Foghorn Therapeutics vs. C4 Therapeutics | Foghorn Therapeutics vs. Prelude Therapeutics | Foghorn Therapeutics vs. Rezolute | Foghorn Therapeutics vs. Shattuck Labs |
| Nurix Therapeutics vs. Foghorn Therapeutics | Nurix Therapeutics vs. Shattuck Labs | Nurix Therapeutics vs. Monte Rosa Therapeutics | Nurix Therapeutics vs. Kymera Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |